Augmentin Dosing for Dental Abscess
For adults with a dental abscess, prescribe Augmentin (amoxicillin-clavulanate) 875 mg/125 mg orally twice daily for 5 days, but only after surgical drainage has been performed or arranged—antibiotics alone are insufficient and surgery is the cornerstone of treatment. 1
Primary Treatment Principle
- Surgical intervention (incision and drainage, root canal therapy, or tooth extraction) is mandatory and must not be delayed; antibiotics serve only as adjuncts to definitive surgical management. 1
- Multiple systematic reviews demonstrate no statistically significant improvement in pain or swelling when antibiotics are added to surgical treatment in localized abscesses without systemic involvement. 1
When Antibiotics Are Actually Indicated
Add antibiotics to surgical management only when one or more of the following are present:
- Systemic signs: fever, tachycardia, tachypnea, or elevated white blood cell count 1
- Spreading infection: cellulitis, diffuse facial swelling, or rapidly progressing infection beyond the tooth 1
- Immunocompromised status: diabetes, chronic cardiac/hepatic/renal disease, or age >65 years 1
- Recent antibiotic use: any β-lactam antibiotic within the past 30 days mandates Augmentin instead of amoxicillin alone due to increased risk of β-lactamase-producing organisms 1
- Moderate to severe symptoms or previous treatment failure with amoxicillin 1
Adult Dosing Regimens
Standard Dose
- Augmentin 875 mg/125 mg orally twice daily for 5 days is the standard regimen for adults with systemic involvement or spreading infection. 1
High-Dose Regimen
- Augmentin 2000 mg orally twice daily (or 90 mg/kg/day divided twice daily) for severe infections or high-risk patients. 1
Renal Dosing Adjustments
- CrCl 10–30 mL/min: Augmentin 875 mg/125 mg once daily (or 500 mg/125 mg every 12 hours) 1
- CrCl <10 mL/min: Augmentin 875 mg/125 mg once daily 1
- Hemodialysis: Administer dose after each dialysis session 1
Pediatric Dosing
- 90 mg/kg/day of amoxicillin component divided twice daily (maximum 875 mg per dose) for children with dental abscess requiring antibiotic therapy. 1
- Pediatric dosing of 25–50 mg/kg/day divided into 3–4 doses is an alternative regimen. 1
Penicillin-Allergic Patients
Non-Severe Allergy
- Clindamycin 300–450 mg orally three times daily for 5–7 days is the preferred alternative for penicillin-allergic adults. 1
- Pediatric clindamycin dosing: 10–20 mg/kg/day in 3 divided doses. 1
- Second- or third-generation cephalosporins (cefdinir, cefuroxime, cefpodoxime) can be safely used in patients with non-severe penicillin allergy. 1
Severe Allergy (Both Penicillin and Clindamycin)
- Doxycycline 100 mg orally twice daily for 5–7 days provides broad-spectrum coverage including aerobic and anaerobic oral pathogens. 1
- Contraindicated in children <8 years and pregnant women. 1
- Trimethoprim-sulfamethoxazole 1–2 double-strength tablets (160/800 mg) orally twice daily for 5–7 days is a third-line alternative. 1
Severe Infections Requiring IV Therapy
When to Hospitalize
- Risk of airway compromise 1
- Systemic toxicity with fever and altered mental status 1
- Deep tissue involvement or cervicofacial extension 1
IV Regimens
- Ampicillin-sulbactam 1.5–3.0 g IV every 6 hours is the preferred IV regimen for severe odontogenic infections. 1
- Piperacillin-tazobactam 3.375 g IV every 6 hours or 4.5 g IV every 8 hours for severe infections with systemic toxicity or deep tissue involvement. 1
- Ceftriaxone 1 g IV every 24 hours plus metronidazole 500 mg IV every 8 hours is an alternative broad-spectrum regimen. 1
- Clindamycin 600–900 mg IV every 6–8 hours for penicillin-allergic patients (pediatric: 10–13 mg/kg/dose IV every 6–8 hours). 1
Transition to Oral Therapy
- Total antibiotic duration is 5–10 days based on clinical response, with a maximum of 7 days in most cases with adequate source control. 1
- Transition to oral clindamycin 300–450 mg three times daily after clinical improvement. 1
Treatment Failures
- If no improvement within 2–3 days on amoxicillin alone, switch to Augmentin, cefuroxime, or add metronidazole to amoxicillin. 2
- Consider amoxicillin-clavulanate for enhanced anaerobic coverage, which is critical since dental abscesses involve mixed anaerobic biofilms. 1
Critical Pitfalls to Avoid
- Never prescribe antibiotics without arranging surgical drainage—this represents fundamental treatment failure. 1
- Do not extend treatment beyond 7 days in most cases with adequate source control. 1
- Avoid fluoroquinolones—they are inadequate for typical dental abscess pathogens. 1
- Do not use metronidazole as monotherapy—it must be combined with amoxicillin or another agent. 1
Evidence Quality
- High-quality evidence from randomized controlled trials demonstrates that amoxicillin-clavulanate achieves 88.2% clinical success rates in acute odontogenic infections, comparable to clindamycin (89.7%). 3
- Bacterial strains isolated from dental abscesses show 76.6% susceptibility to amoxicillin and 89.2% to cephalexin in early-stage infections. 4
- The vast majority (96%) of bacterial strains from dentoalveolar abscesses are sensitive to penicillin-based antibiotics. 5